Hyundai Pharmaceutical Co., Ltd. (KRX:004310)
7,760.00
-410.00 (-5.02%)
At close: Oct 8, 2026
Hyundai Pharmaceutical Market Cap
Hyundai Pharmaceutical has a market cap or net worth of 214.78 billion as of October 9, 2026. It is the 22,354th most valuable company in the world and the 845th biggest in South Korea. Its market cap has increased by 100.52% in one year.
Market Cap
214.78B
Enterprise Value
n/a
Revenue
108.14B
Global Rank
Country Rank
#845 South Korea
PE Ratio
128.61
ChartMarket Cap Chart
Since August 30, 1995, Hyundai Pharmaceutical's market cap has increased from 28.77B to 214.78B, an increase of 646.41%. That is a compound annual growth rate of 6.67%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2026 | 214.78B | -8.92% |
| Dec 30, 2025 | 235.81B | 137.66% |
| Dec 30, 2024 | 99.22B | -12.77% |
| Dec 28, 2023 | 113.76B | -14.20% |
| Dec 29, 2022 | 132.58B | -19.22% |
| Dec 30, 2021 | 164.12B | -22.93% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Korea United Pharm | 255.22B |
| Samjin Pharmaceuticals | 246.38B |
| Suheung | 225.51B |
| AptaBio Therapeutics | 223.06B |
| Huons | 221.38B |
| BNC KOREA | 209.29B |
| FutureChem Co.,Ltd | 189.42B |
| Yungjin Pharm. | 189.29B |